Gadavist Contrast Media Gadobutrol 1 mmol / mL Intravenous Injection Single Dose Vial 15 mL , 20/Case MC 50419032513

Gadavist Contrast Media Gadobutrol 1 mmol / mL Intravenous Injection Single Dose Vial 15 mL , 20/Case MC 50419032513

1- REGULATIONS ON PURCHASE OF THESE PRODUCTS VARY FROM STATE TO STATE . IT IS THE PURCHASER'S RESPONSIBILITY TO KNOW AND COMPLY WITH THE LAWS GOVERNING THE DISTRICT IN WHICH THEY LIVE. 2-THESE ITEMS WOULD BE USED ONLY BY QUALIFIED CUSTOMERS ( PHYSICIAN OFFICES , DIAGNOSTIC & RESEARCH LABORATORIES , HEALTH CARE PROVIDERS , .... ) WITH VALID PROFESSIONAL LICENSE. 3- ANY INQUIRY REGARDING THESE ITEMS WOULD BE PROCESSED AFTER VERIFICATION OF VALID LICENSE TO BE EMAILED AS AN ATTACHMENT TO : ADMIN@ALLMEDTECH.COM OR FAXED TO 323-782-0985 )

Manufacturer # 50419032513 Brand Gadavist™ Manufacturer McKesson Specialty Application Contrast Media Container Type Single Dose Vial Dosage Form Injection Generic Drug Code 27133 Generic Drug Name Gadobutrol NDC Number 50419-0325-13 Storage Requirements USP Controlled Room Temperature Strength 1 mmol / mL Type Intravenous UNSPSC Code 51441500 User 2 Years of Age and Older Volume 15 mL Features

GADAVIST™ is a gadolinium-based contrast agent indicated for intravenous use in diagnostic magnetic resonance imaging (MRI) in adults and children (2 years of age and older) to detect and visualize areas with disrupted blood brain barrier (BBB) and/or abnormal vascularity of the central nervous system Gadavist is formulated at a higher concentration (1 mmol/mL) compared to certain other gadolinium-based contrast agents, resulting in a lower volume of administration Gadavist injection contains 1 mmol gadobutrol/mL (equivalent to 604.72 mg gadobutrol/mL) Case pack of 20 vials (2 inner packs x 10 vials) Store at 25°C (77°F); excursions permitted to 15 - 30°C (59 - 86°F)